Johnson & Johnson/ViiV's once-monthly, injectable drug combination for HIV shows comparable efficacy to daily oral treatment in two trials.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.